Literature DB >> 12034169

Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade.

S Ferrari-Lacraz1, X X Zheng, Y S Kim, W Maslinski, T B Strom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12034169      PMCID： PMC3807826          DOI： 10.1016/s0041-1345(01)02900-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  19 in total

1.  CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.

Authors:  N D Jones; A Van Maurik; M Hara; B M Spriewald; O Witzke; P J Morris; K J Wood
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

Authors:  C P Larsen; E T Elwood; D Z Alexander; S C Ritchie; R Hendrix; C Tucker-Burden; H R Cho; A Aruffo; D Hollenbaugh; P S Linsley; K J Winn; T C Pearson
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

3.  Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.

Authors:  D W Chae; Y Nosaka; T B Strom; W Maslinski
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

4.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.

Authors:  J Strehlau; M Pavlakis; M Lipman; M Shapiro; L Vasconcellos; W Harmon; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.

Authors:  X G Smith; E M Bolton; H Ruchatz; X Wei; F Y Liew; J A Bradley
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

6.  Control of homeostasis of CD8+ memory T cells by opposing cytokines.

Authors:  C C Ku; M Murakami; A Sakamoto; J Kappler; P Marrack
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

7.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

Authors:  D J Lenschow; Y Zeng; J R Thistlethwaite; A Montag; W Brady; M G Gibson; P S Linsley; J A Bluestone
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

8.  IL-2 knockout recipient mice reject islet cell allografts.

Authors:  J Steiger; P W Nickerson; W Steurer; M Moscovitch-Lopatin; T B Strom
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

9.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  Receptor antagonist and selective agonist derivatives of mouse interleukin-2.

Authors:  S M Zurawski; G Zurawski
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598
View more
  1 in total

1.  CD122 signaling in CD8+ memory T cells drives costimulation-independent rejection.

Authors:  David V Mathews; Ying Dong; Laura B Higginbotham; Steven C Kim; Cynthia P Breeden; Elizabeth A Stobert; Joseph Jenkins; J Yun Tso; Christian P Larsen; Andrew B Adams
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.